logo

Exhibiting at Hi Korea 2024

F41
Hall A, COEX, Seoul, Korea
27 Aug - 29 Aug, 2024

Product Offerings

Product Categories:

Organoids, Drug Evaluation, AI Analysis

Products:

Patient-Derived Organoids (PDO), Organoid Culture, Drug Evaluation Platforms, AI-Based Analysis Algorithms

Product Gallery:

Gradiant Bioconvergence specializes in the development and application of organoid culture technology, providing comprehensive contract research services. The company focuses on patient-derived organoid (PDO) banking, drug evaluation platforms, and AI-based analysis algorithms to support innovative drug discovery and development.